Defibrillation Power Point Presentation

Embed Size (px)

Citation preview

  • 8/3/2019 Defibrillation Power Point Presentation

    1/27

    Special Considerations in Pediatric Advanced LifeSupport (PALS)

    1.Simultanous Actions Chest compressions should be immediately started by one rescuer,

    while a second rescuer prepares to start ventilations with a bag and

    mask.

    The effectiveness of PALS is dependent on high-quality CPR, which

    requires an adequate compression rate (at least 100

    compressions/min), an adequate compression depth (at least one thirdof the AP diameter of the chest or approximately 1 inches [4 cm] in

    infants and approximately 2 inches [5 cm] in children), allowing

    complete recoil of the chest after each compression, minimizing

    interruptions in compressions, and avoiding excessive ventilation.

    While one rescuer performs chest compressions and another performsventilations, other rescuers should obtain a monitor/defibrillator,

    establish vascular access, and calculate and prepare the anticipated

    medications.

  • 8/3/2019 Defibrillation Power Point Presentation

    2/27

    2.Monitored Patients

    3. Respiratory Failure

    -Respiratory failure is characterized by inadequate ventilation,

    insufficient oxygenation, or both. Anticipate respiratoryfailure if any of the following signs is present:

    An increased respiratory rate, particularly with signs of

    distress (eg, increased respiratory effort including nasal

    flaring, retractions, seesaw breathing, or grunting)

    An inadequate respiratory rate, effort, or chest excursion

    (eg, diminished breath sounds or gasping), especially if

    mental status is depressedCyanosis with abnormal breathing despite

    supplementary oxygen

  • 8/3/2019 Defibrillation Power Point Presentation

    3/27

    4.Shock-Shock results from inadequate blood flow and oxygen

    delivery to meet tissue metabolic demands. The mostcommon type of shock in children is hypovolemic,

    including shock due to hemorrhage.

    Typical signs of compensated shock include:

    Tachycardia

    Cool and pale distal extremities

    Prolonged (>2 seconds) capillary refill (despite warm

    ambient temperature)Weak peripheral pulses compared with central pulses

    Normal systolic blood pressure

  • 8/3/2019 Defibrillation Power Point Presentation

    4/27

    Depressed mental status

    Decreased urine output

    Metabolic acidosis

    Tachypnea

    Weak central pulsesDeterioration in color

  • 8/3/2019 Defibrillation Power Point Presentation

    5/27

    5. Airways

    Oropharyngeal and Nasopharyngeal Airways

    Laryngeal Mask Airway (LMA)

    Oxygen Pulse Oximetry

    Bag-Mask Ventilation

    Gastric Inflation

    Ventilation With an Endotracheal TubeAfter intubation, secure the tube. After securing

    the tube, maintain the patient's head in a neutral

    position; neck flexion may push the tube farther

    into the airway, and extension may pull the tubeout of the airway.

  • 8/3/2019 Defibrillation Power Point Presentation

    6/27

    If an intubated patient's condition deteriorates, consider

    the following possibilities :

    Displacement of the tube

    Obstruction of the tube

    Pneumothorax

    Equipment failure

  • 8/3/2019 Defibrillation Power Point Presentation

    7/27

    POSTRESUSCITATION STABILIZATION (POST CARDIACARREST CARE)

    The goals of post resuscitation care are to preserve

    neurologic function, prevent secondary organ injury,

    diagnose and treat the cause of illness, and enable the

    patient to arrive at a pediatric tertiary-care facility in anoptimal physiologic state.

  • 8/3/2019 Defibrillation Power Point Presentation

    8/27

    Respiratory System

    Nursing Management:

    1.Assist ventilation if there is significant respiratory

    compromise (tachypnea, respiratory distress with

    agitation or decreased responsiveness, poor air exchange,

    cyanosis, hypoxemia). If the patient is already intubated,

    verify tube position, patency, and security.

  • 8/3/2019 Defibrillation Power Point Presentation

    9/27

    2.Control pain and discomfort with analgesics (eg, fentanyl or

    morphine) and sedatives (eg, lorazepam or midazolam).Neuromuscular blocking agents (eg, vecuronium or

    pancuronium) with analgesia or sedation, or both, may

    improve oxygenation and ventilation in case of patient-

    ventilator dyssynchrony or severely compromised

    pulmonary function. Neuromuscular blockers, however, can

    mask seizures and impede neurologic examinations.

    3.Monitor exhaled CO2 (PETCO2), especially during transportand diagnostic procedures

    4.Insert a gastric tube to relieve and help prevent gastric

    inflation.

  • 8/3/2019 Defibrillation Power Point Presentation

    10/27

    Cardiovascular System

    1.Monitor heart rate and blood pressure.

    2.Repeat clinical evaluations at frequent intervals until thepatient is stable. Consider monitoring urine output with

    an indwelling catheter.

    3.Performing ECG may be helpful in establishing the causeof the cardiac arrest.

    4. Monitor venous or arterial blood gas analysis and serum

    electrolytes, glucose, and calcium concentrations.

    5.A chest x-ray should be performed to evaluateendotracheal tube position, heart size, and pulmonary

    status.

    6.Assess adequacy of tissue oxygen delivery

  • 8/3/2019 Defibrillation Power Point Presentation

    11/27

    Neurologic System

    A primary goal of resuscitation is to preserve brain function.

    Limit the risk of secondary neuronal injury by adhering to

    the following precautions:Nursing Management:

    1.Do not routinely provide excessive ventilation or

    hyperventilation.

    2.Prevent shivering by providing sedation and, if needed,neuromuscular blockade, recognizing that this can mask

    seizure activity.

    3.Closely watch for signs of infection and other potential

    complications of hypothermia include diminished cardiac

    output, arrhythmia, pancreatitis, coagulopathy,

    thrombocytopenia, hypophosphatemia, hypovolemia from

    cold diuresis, hypokalemia, and hypomagnesemia.

  • 8/3/2019 Defibrillation Power Point Presentation

    12/27

    4.Monitor temperature continuously and treat fever (>38C)

    aggressively with antipyretics and cooling devices because

    fever adversely influences recovery from ischemic braininjury.

    5.Treat postischemic seizures aggressively

    6.Identify for a correctable metabolic cause such as

    hypoglycemia or electrolyte imbalance.7.Avoid rewarming from 32 to 34C faster than 0.5C per 2

    hours unless the patient requires rapid rewarming for

    clinical reasons.

  • 8/3/2019 Defibrillation Power Point Presentation

    13/27

    Renal System

    Decreased urine output (

  • 8/3/2019 Defibrillation Power Point Presentation

    14/27

    Medications to Maintain Cardiac Output and forPostresuscitation Stabilization

    Epinephrine Low-dose infusions (03 mcg/kg per minute) cause -adrenergic vasoconstriction.

    Epinephrine or norepinephrine may be preferable in

    patients (especially infants) with marked circulatory

    instability and decompensated shock.

  • 8/3/2019 Defibrillation Power Point Presentation

    15/27

    Dopamine

    Dopamine can produce direct dopaminergic effects and

    indirect - and -adrenergic effects through stimulation of

    norepinephrine release.Titrate dopamine to treat shock that is unresponsive to

    fluids and when systemic vascular resistance is low .

    Typically a dose of 2 to 20 mcg/kg per minute is used.

    Although low-dose dopamine infusion has been frequently

    recommended to maintain renal blood flow or improve

    renal function

    At higher doses (>5 mcg/kg per minute), dopaminestimulates cardiac -adrenergic receptors, but this effect

    may be reduced in infants and in patients with chronic

    congestive heart failure. Infusion rates >20 mcg/kg per

    minute may result in excessive vasoconstriction.

  • 8/3/2019 Defibrillation Power Point Presentation

    16/27

    Dobutamine Hydrochloride

    Dobutamine has a relatively selective effect on 1- and

    2-adrenergic receptors due to effects of the twoisomers; one is an -adrenergic agonist, and the other is

    an -adrenergic antagonist.

    Dobutamine increases myocardial contractility and can

    decrease peripheral vascular resistance, improve cardiacoutput and blood pressure due to poor myocardial

    function.

  • 8/3/2019 Defibrillation Power Point Presentation

    17/27

    Norepinephrine

    Norepinephrine is a potent vasopressor promoting

    peripheral vasoconstriction,treat shock with low systemicvascular resistance (septic, anaphylactic, spinal, or

    vasodilatory) unresponsive to fluid.

  • 8/3/2019 Defibrillation Power Point Presentation

    18/27

    Sodium Nitroprusside

    Sodium nitroprusside increases cardiac output by

    decreasing vascular resistance (afterload). If hypotension is related to poor myocardial function,

    consider using a combination of sodium nitroprusside to

    reduce afterload and an inotrope to improve contractility.

    Fluid administration may be required secondary tovasodilatory effects.

  • 8/3/2019 Defibrillation Power Point Presentation

    19/27

    Inodilators

    Inodilators (inamrinone and milrinone) augment cardiac

    output with little effect on myocardial oxygen demand. Itis reasonable to use an inodilator in a highly monitored

    setting for treatment of myocardial dysfunction with

    increased systemic or pulmonary vascular resistance.

    Administration of fluids may be required secondary tovasodilatory effects.

    N i R ibiliti i D fib ill ti

  • 8/3/2019 Defibrillation Power Point Presentation

    20/27

    Nursing Responsibilities in Defibrillation

    Before

    1. Identify ventricular fibrillation (VF) on the monitor.Check leads, confirm pulselessness.

    2. Call an arrest. Notify physician STAT.

    3. If arrest is witnessed, give precordial pump.

    4. Initiate CPR until defibrillator available.

    P ti t f d fib ill ti

  • 8/3/2019 Defibrillation Power Point Presentation

    21/27

    Prepare patient for defibrillation:

    side rail down bed and patient flat

    apply gel pads in correct position

    one pad on upper chest, below the right clavicle and thesecond pad below the left nipple at the midaxillary line

    as shown below

    place pads at least 2 cm. away from electrodes and 10

    cm away from a pacemaker generator

    Pad Placement:

    place one pad over the precordium, to the left of the

    lower sternal border position the second pad on the back, opposite the front

    pad

    press pads firmly onto the skin, moving any air pockets

    to the outer edges. Connect R2 pads to the R2 cable

    D i

  • 8/3/2019 Defibrillation Power Point Presentation

    22/27

    During

    1. Prepare the machine for defibrillation:

    Plug cart in

    Turn defibrillator on and ensure setting is "defib" Set charge at 200 joules.

    Hold paddles firmly to chest until charge is complete.

    Ensure that paddles to not come in contact with ECG leads.

    2. Ensure there is no contact with metal on bed, and allpersonnel are away from bed contact.

    3. Call "ALL CLEAR".

    P ddl fi l t l d l i 25 30 lb

  • 8/3/2019 Defibrillation Power Point Presentation

    23/27

    Press paddles firmly onto gel pads applying 25-30 lbs

    pressure.

    Discharge by simultaneously depressing buttons on

    paddle. Be sure to depress buttons firmly and hold for 2

    seconds.

    Deliver shock following exhalation.

    Immediately press charge button on paddles withoutremoving the paddles from the chest. Have a second

    person reset charge to 300 Joules.

    Quickly reassess rhythm while paddles are recharging to

    ensure that rhythm conversion has not occurred;

    proceed to deliver the second shock as soon as the

    paddles are charged. Immediately press charge button

    on paddles without removing the paddles from the

    chest. Have a second person reset charge to 360 Joules.

  • 8/3/2019 Defibrillation Power Point Presentation

    24/27

    Between initial 3 shocks: do not lift paddles from the chest

    do not pause for pulse check

    recharge as soon as first shock is delivered

    do not resume CPR between shocks

    do not stop for medications

    4 Defibrillate as per step 4 if VF or p lseless VT persists

  • 8/3/2019 Defibrillation Power Point Presentation

    25/27

    4.Defibrillate as per step 4 if VF or pulseless VT persists.

    5.Administer 1 mg epinephrine IV push as per procedure

    and q 5 minutes following initial 3 shocks.

    (alternatively, the physician may order 40 unitsvasopressin X 1 dose).

    6.Continue to manage ABCs between shocks.

    7.possible causes of non-responsive VT/VF (e.g. electrolyte

    or acid-base disturbance, pulmonary artery catheter inright ventricular position, hypoxemia, hypothermia).

    8.Ensure adequate paddle pressure, machine off

    synchronization.

  • 8/3/2019 Defibrillation Power Point Presentation

    26/27

    After

    If successful:

    1. Administer 1 mg/kg lidocaine bolus, and start aninfusion at 2 mg/min

    2. Evaluate and maintain ABC's

    3. Evaluate serum electrolytes, blood gases and pulmonary

    artery position.4. Obtain order for electrolyte replacement if required.

    5. Correct problems with pulmonary artery placement.

    6. Correct acid-base disturbances.

    7. Assess and treat for side effects: burns, arrhythmias,anxiety.

    8. Post rhythm strips in chart and document on the cardiacarrest record.

  • 8/3/2019 Defibrillation Power Point Presentation

    27/27